Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets.

Zhang, Yufeng; Wo, Siu Kwan; Leng, Wei; Gao, Fang; Yan, Xiaoyu; Zuo, Zhong

Zhang, Yufeng; Wo, Siu Kwan; Leng, Wei; Gao, Fang; Yan, Xiaoyu; Zuo, Zhong.

Afiliación

Zhang Y; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region.
Wo SK; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region.
Leng W; Europharm Laboratoires Co. Ltd., 12-14 Dai Wang Street, Tai Po Industrial Estate, Tai Po, New Territories, Hong Kong Special Administrative Region.
Gao F; Europharm Laboratoires Co. Ltd., 12-14 Dai Wang Street, Tai Po Industrial Estate, Tai Po, New Territories, Hong Kong Special Administrative Region.
Yan X; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region.
Zuo Z; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region. Electronic address: joanzuo@cuhk.edu.hk.

J Control Release ; 346: 275-288, 2022 06.

Article en En | MEDLINE | ID: mdl-35461968

Asunto(s)

Colitis Ulcerosa; Mesalamina; Disponibilidad Biológica; Humanos; Intestino Delgado/metabolismo; Mesalamina/metabolismo; Solubilidad; Comprimidos; Comprimidos Recubiertos/metabolismo

Palabras clave

Bioequivalence; In-vitro in-vivo correlation; Mesalazine enteric-coated tablet; NONMEM; Population pharmacokinetics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Mesalamina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google